Kenya will produce vaccines on its own
Kenya has officially launched a World Health Organization (WHO) vaccine technology transfer project.
As part of the technology transfer agreement, the Kenyan BioVax Institute will acquire comprehensive know-how in the field of vaccine production, from research and development to large–scale production.
The project is expected to strengthen local technical expertise, modernize infrastructure, and create a scalable platform for the production of vaccines and therapeutics in the country.
By reducing dependence on imported vaccines and strengthening local production, the country aims to improve health security while ensuring equal access to vital technologies across Africa.
CAPITAL FM
